ATTR with cardiomyopathy

Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection
BioSpace
Thu, 10/26/23 - 10:39 am
Alnylam
Patisiran
clinical trials
FDA
ATTR with cardiomyopathy
Intellia Gets FDA Clearance to Start First Ever Phase III Trial for an In Vivo CRISPR Drug
Xtalks
Mon, 10/23/23 - 10:31 am
Intellia Therapeutics
FDA
NTLA-2001
ATTR with cardiomyopathy